Combining the G‐protein‐coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12‐week trial
Xuejun V. Peng; John F. Marcinak; Marsha G. Raanan; Charlie Cao
Author Information: Takeda Development Center Americas, Inc.
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.